Press Release
T1D Exchange to Present Several Abstracts at the 51st European Association for the Study of Diabetes (EASD) Annual Meeting
Data presented in partnership with T1D Exchange at the 51st Annual Meeting of the European Association for the Study of Diabetes (EASD) support the efficacy and safety of needle-free glucagon nasal powder (GNP) for the treatment of severe hypoglycemia in youth with type 1 diabetes. Read the T1D Exchange press release here.